Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis

OBJECTIVES To investigate the relations between quantitative diffusion coefficient MRI histograms, clinical variables, and cerebral atrophy. METHODS Twenty two patients with clinically definite multiple sclerosis and 11 healthy volunteers were studied. Histograms of apparent diffusion coefficient (ADC) from a volume of interest that included multiple slices encompassing the lateral ventricles were processed from diffusion weighted MRI. In addition, total lesion load was measured on T2 weighted dual echo images, and cerebral volume from 3D magnetisation prepared rapid acquisition gradient echo scans. All patients underwent neurological assessment, including disability on the expanded disability status scale (EDSS). RESULTS Histograms from the patient group showed a reduced peak height and a "right shift" compared with healthy controls. Peak height of the diffusion histogram correlated with both EDSS (r=-0.54, p=0.0101) and disease duration (r=-0.52, p=0.0140), but not with age. Brain volume correlated with peak height of the ADC histogram (r=0.55, p=0.0129), but not with disability. Total lesion load also correlated moderately with EDSS (r=0.46, p=0.03). CONCLUSIONS This study shows for the first time that quantitative MRI measures of diffusion correlate with clinical variables (disability, disease duration) and cerebral atrophy in multiple sclerosis. Cerebral atrophy and fixed neurological deficit may be attributed to axonal loss, which would be expected to have a significant effect on ADC. Extension of this method to more patients and longitudinal studies will further elucidate its sensitivity, reproducibility, and potential role in clinical practice and treatment trials.

[1]  G J Barker,et al.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.

[2]  A J Thompson,et al.  Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.

[3]  R H Edwards,et al.  Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. , 1994, Magnetic resonance imaging.

[4]  R. Herndon,et al.  A longitudinal study of brain atrophy in relapsing multiple sclerosis , 1999, Neurology.

[5]  T. Ptak,et al.  Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. , 1999, AJNR. American journal of neuroradiology.

[6]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[7]  M S Buchsbaum,et al.  Whole-brain diffusion MR histograms differ between MS subtypes , 2000, Neurology.

[8]  R I Grossman,et al.  Total brain N-acetylaspartate , 2000, Neurology.

[9]  P. Grant,et al.  Diffusion MR imaging. Theory and applications. , 1999, Neuroimaging clinics of North America.

[10]  G J Barker,et al.  Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. , 1999, Magnetic resonance imaging.

[11]  G. Comi,et al.  Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI , 2000, Neurology.

[12]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[13]  N. Losseff,et al.  Measures of brain and spinal cord atrophy in multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.

[14]  L D Blumhardt,et al.  Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis , 1999, Journal of neurology, neurosurgery, and psychiatry.

[15]  D G Gadian,et al.  Correction for eddy current induced Bo shifts in diffusion‐weighted echo‐planar imaging , 1999, Magnetic resonance in medicine.

[16]  C. Thomsen,et al.  Increased water self‐diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis , 1993, Acta neurologica Scandinavica.

[17]  G. Barker,et al.  Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis , 1999, Neurology.

[18]  A. Thompson,et al.  Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. , 1996, Brain : a journal of neurology.

[19]  P. Dastidar,et al.  Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis , 1999, Journal of the Neurological Sciences.

[20]  Nikos Evangelou,et al.  Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.

[21]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[22]  A. Thompson,et al.  Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.

[23]  H J Gundersen,et al.  How accurate are measurements on MRI? a study on multiple sclerosis using reliable 3D stereological methods , 1999, Journal of magnetic resonance imaging : JMRI.

[24]  L D Blumhardt,et al.  Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. , 1999, Brain : a journal of neurology.

[25]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[26]  S. Reingold,et al.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.

[27]  R I Grossman,et al.  Magnetization transfer histogram methodology: its clinical and neuropsychological correlates. , 1999, Neurology.

[28]  D D Blatter,et al.  Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. , 1995, AJNR. American journal of neuroradiology.

[29]  David H. Miller,et al.  Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance , 1996, Magnetic resonance in medicine.

[30]  Identification of brain atrophy with MRI in MS , 1998, Multiple sclerosis.

[31]  V. Stevenson,et al.  Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis , 1999, Multiple sclerosis.

[32]  R. Grossman Application of magnetization transfer imaging to multiple sclerosis. , 1999, Neurology.